πŸ“¦ Free Express Shipping on orders over $150 β€” Australia-wide
β€’ πŸ’Ž Save up to 22% β†’
Aventris Labs

Batch Verification Report

Batch verification and analytical summary for FOXO4-DRI (all-D-amino acid retro-inverso 46-mer peptide reference material).

BVR ID: FOX4-BVR-20260305
Revision: 1.0
Research Use Only
Product
FOXO4-DRI
Composition
FOXO4-DRI
Filler-free lyophilised peptide powder · No mannitol or bulking agents
Intended Use
Laboratory research and analytical reference applications only.
Batch & Dates
Manufacturer Lot: P260114-M144
Manufacture date: 14 Jan 2026
Recommended retest date: As per manufacturer records
Form & Amount
Form: Lyophilised peptide powder (white)
Amount: As specified on Aventris product label
Storage
Store in a cool, dry place away from light. Follow Aventris storage guidance on the product label.

Analytical Results

The following analytical data was obtained from manufacturer testing of the source batch. Aventris has independently verified this data against our quality specifications. This Batch Verification Report summarises our review findings for FOXO4-DRI.

FOXO4-DRI Lot P260114-M144  ·  All-D-AA 46-mer  ·  Mw 5358.06  ·  D-allo-Ile at Ile positions
TestMethodSpecificationResult
Purity (HPLC)HPLCβ‰₯98.0%98.36%
Peptide Content (N%)Nitrogen analysis (N%)β‰₯75.0%85.71%
Molecular Weight (ESI-MS)ESI-MS5358.06 Β±1.0 Da5358.11 Da
Water Content (Karl Fischer)Karl Fischer≀10.0%4.09%
Acetate Content (HPLC)HPLC (ion chromatography)≀12.0%11.82%
Related Substances – Any IndividualHPLC≀1.0%≀0.46%
Mass BalanceGravimetric95.0–105.0%Conforms

Storage & Handling

Storage Conditions:

  • Store at −20°C or below in original sealed vial
  • Protect from light and moisture
  • Do not freeze-thaw repeatedly once reconstituted
  • Recommended shelf life: 24 months when stored properly

General Laboratory Handling:

  • Handle using standard laboratory safety practices
  • Wear appropriate personal protective equipment
  • Use in well-ventilated area or fume hood
  • Avoid inhalation, ingestion, or skin/eye contact

Reconstitution:
Reconstitution methods, diluents, and working concentrations must be determined by qualified researchers according to their specific experimental protocols and institutional guidelines. Aventris does not provide reconstitution instructions.

Peptide Sequence:

ltlrkepaseiaqsileaysqngwanrrsggkrppprrrqrrkkrg
(all D-amino acids; D-allo-Ile used in place of D-Ile at Ile residues)

All-D-amino acid 46-mer retro-inverso peptide; sequence shown in single-letter D-AA notation

Molecular Identity:

  • C228H388N86O64 — MW 5358.06 Da

Additional Documentation:
For questions about this batch or to request additional information, contact [email protected]

Scroll to Top